Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS AVANOS MEDICAL	$10.81 +2.8%	$11.85	$9.30 ▼ $25.36	$488.15M	1.12	634,187 shs	591,653 shs
CNMD CONMED	$54.10 +3.1%	$52.54	$46.00 ▼ $78.19	$1.62B	1.17	616,571 shs	466,255 shs
EYE National Vision	$23.02 +1.2%	$23.59	$9.56 ▼ $25.67	$1.80B	1.27	2.19 million shs	2.65 million shs
LMAT LeMaitre Vascular	$94.38 +1.9%	$83.82	$71.42 ▼ $109.58	$2.10B	0.79	156,905 shs	215,588 shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS AVANOS MEDICAL	-2.36%	-6.73%	-11.92%	-17.48%	-53.28%
CNMD CONMED	-3.99%	-1.75%	+2.58%	-12.57%	-21.68%
EYE National Vision	+0.59%	-9.16%	-6.89%	+20.75%	+121.54%
LMAT LeMaitre Vascular	+0.37%	+9.79%	+10.68%	+11.22%	+10.58%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVNS AVANOS MEDICAL	1.6016 of 5 stars	0.0	3.0	0.0	0.0	0.9	1.7	2.5
CNMD CONMED	4.389 of 5 stars	2.1	3.0	2.5	4.3	2.1	0.0	3.1
EYE National Vision	2.8652 of 5 stars	2.3	2.0	0.0	3.3	3.3	0.8	0.0
LMAT LeMaitre Vascular	2.1773 of 5 stars	1.3	3.0	3.3	0.0	2.1	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVNS AVANOS MEDICAL	0.00	N/A	N/A	N/A
CNMD CONMED	2.20	Hold	$59.80	10.53% Upside
EYE National Vision	2.60	Moderate Buy	$24.73	7.42% Upside
LMAT LeMaitre Vascular	2.50	Moderate Buy	$98.00	3.84% Upside

Current Analyst Ratings Breakdown

Latest AVNS, EYE, LMAT, and CNMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/7/2025	EYE National Vision	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$17.00 ➝ $22.00
8/7/2025	EYE National Vision	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$24.00 ➝ $27.00
8/7/2025	EYE National Vision	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$30.00 ➝ $28.00
8/6/2025	LMAT LeMaitre Vascular	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$92.00 ➝ $95.00
8/6/2025	LMAT LeMaitre Vascular	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$95.00
7/31/2025	CNMD CONMED	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$80.00 ➝ $68.00
7/30/2025	EYE National Vision	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$36.00
7/23/2025	EYE National Vision	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$15.00 ➝ $24.00
7/22/2025	LMAT LeMaitre Vascular	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
7/8/2025	EYE National Vision	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$30.00
7/8/2025	EYE National Vision	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$30.00

(Data available from 8/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVNS AVANOS MEDICAL	$687.80M	0.73	$12.15 per share	0.89	$16.73 per share	0.65
CNMD CONMED	$1.31B	1.28	$6.93 per share	7.81	$32.40 per share	1.67
EYE National Vision	$1.82B	1.00	$1.65 per share	13.91	$10.74 per share	2.14
LMAT LeMaitre Vascular	$219.86M	9.72	$2.43 per share	38.77	$16.02 per share	5.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVNS AVANOS MEDICAL	-$392.10M	-$10.07	N/A	6.25	N/A	-66.89%	6.16%	4.57%	10/29/2025 (Estimated)
CNMD CONMED	$132.42M	$3.53	15.33	10.67	1.79	8.31%	14.43%	6.05%	10/29/2025 (Estimated)
EYE National Vision	-$28.50M	-$0.18	N/A	85.26	2.74	-0.75%	3.56%	1.49%	N/A
LMAT LeMaitre Vascular	$44.04M	$2.06	45.82	43.49	2.38	20.08%	13.67%	9.14%	10/30/2025 (Estimated)

Latest AVNS, EYE, LMAT, and CNMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q2 2025	EYE National Vision	$0.12	$0.18	+$0.06	$0.11	$469.21 million	$486.42 million
8/5/2025	Q2 2025	AVNS AVANOS MEDICAL	$0.18	$0.17	-$0.01	-$1.66	$165.50 million	$175.00 million
8/5/2025	Q2 2025	LMAT LeMaitre Vascular	$0.57	$0.60	+$0.03	$0.60	$62.48 million	$63.15 million
7/30/2025	Q2 2025	CNMD CONMED	$1.13	$1.15	+$0.02	$0.69	$338.42 million	$342.35 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVNS AVANOS MEDICAL	N/A	N/A	N/A	N/A	N/A
CNMD CONMED	$0.80	1.48%	N/A	22.66%	N/A
EYE National Vision	N/A	N/A	N/A	N/A	N/A
LMAT LeMaitre Vascular	$0.80	0.85%	N/A	38.83%	14 Years

Latest AVNS, EYE, LMAT, and CNMD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/8/2025	CNMD CONMED	quarterly	$0.20	1.5%	9/15/2025	9/15/2025	10/3/2025
7/30/2025	LMAT LeMaitre Vascular	quarterly	$0.20	0.9%	8/21/2025	8/21/2025	9/4/2025
5/21/2025	CNMD CONMED	quarterly	$0.20	1.34%	6/13/2025	6/13/2025	7/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVNS AVANOS MEDICAL	0.12	2.64	1.58
CNMD CONMED	0.88	2.23	1.00
EYE National Vision	0.30	0.52	0.31
LMAT LeMaitre Vascular	0.46	13.96	11.74

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVNS AVANOS MEDICAL	95.17%
CNMD CONMED	N/A
EYE National Vision	N/A
LMAT LeMaitre Vascular	84.64%

Insider Ownership

Company	Insider Ownership
AVNS AVANOS MEDICAL	2.64%
CNMD CONMED	3.10%
EYE National Vision	2.70%
LMAT LeMaitre Vascular	9.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVNS AVANOS MEDICAL	2,227	46.40 million	45.18 million	Optionable
CNMD CONMED	3,900	30.95 million	30.00 million	Optionable
EYE National Vision	13,411	79.20 million	77.06 million	Optionable
LMAT LeMaitre Vascular	490	22.64 million	20.49 million	Optionable

AVNS, EYE, LMAT, and CNMD Headlines

Recent News About These Companies

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Townsquare Capital LLC

August 12 at 5:11 AM | marketbeat.com

LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why

August 11 at 1:46 PM | zacks.com

Insider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO Sells 100,000 Shares of Stock

August 10 at 5:58 PM | marketbeat.com

Roth Capital Lifts Earnings Estimates for LeMaitre Vascular

August 10 at 2:47 AM | americanbankingnews.com

What is Barrington Research's Forecast for LMAT Q3 Earnings?

August 9 at 8:30 AM | marketbeat.com

Q3 EPS Forecast for LeMaitre Vascular Lifted by Analyst

August 9 at 8:30 AM | marketbeat.com

LeMaitre Vascular (NASDAQ:LMAT) Upgraded at Barrington Research

August 9 at 2:31 AM | americanbankingnews.com

Q2 EPS Estimate for LeMaitre Vascular Lifted by Analyst

August 8, 2025 | marketbeat.com

Roth Capital Expects Stronger Earnings for LeMaitre Vascular

August 8, 2025 | americanbankingnews.com

LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Up After Strong Earnings

August 8, 2025 | americanbankingnews.com

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Declares Quarterly Dividend of $0.20

August 7, 2025 | marketbeat.com

Cantor Fitzgerald Issues Positive Forecast for LeMaitre Vascular (NASDAQ:LMAT) Stock Price

August 7, 2025 | marketbeat.com

LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Up Following Better-Than-Expected Earnings

August 7, 2025 | marketbeat.com

LeMaitre Vascular (NASDAQ:LMAT) Stock Rating Upgraded by Barrington Research

August 7, 2025 | marketbeat.com

LeMaitre Vascular (NASDAQ:LMAT) Releases Earnings Results, Beats Expectations By $0.03 EPS

August 6, 2025 | marketbeat.com

LeMaitre Vascular (NASDAQ:LMAT) Issues FY 2025 Earnings Guidance

August 6, 2025 | marketbeat.com

LeMaitre Vascular (NASDAQ:LMAT) Updates Q3 2025 Earnings Guidance

August 6, 2025 | marketbeat.com

Why LeMaitre (LMAT) Stock Is Trading Up Today

August 6, 2025 | uk.finance.yahoo.com

LeMaitre Vascular Inc (LMAT) Q2 2025: Everything You Need To Know Ahead Of Earnings

August 6, 2025 | finance.yahoo.com

LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ...

August 6, 2025 | finance.yahoo.com

LeMaitre (LMAT) Q2 Revenue Jumps 15%

August 6, 2025 | fool.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

AVNS, EYE, LMAT, and CNMD Company Descriptions

AVANOS MEDICAL NYSE:AVNS

$10.81 +0.29 (+2.77%)

Closing price 03:59 PM Eastern

Extended Trading

$10.80 -0.02 (-0.15%)

As of 04:30 PM Eastern

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

CONMED NYSE:CNMD

$54.10 +1.62 (+3.09%)

Closing price 03:59 PM Eastern

Extended Trading

$54.02 -0.09 (-0.16%)

As of 07:47 PM Eastern

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

National Vision NASDAQ:EYE

$23.02 +0.27 (+1.19%)

Closing price 04:00 PM Eastern

Extended Trading

$23.02 0.00 (0.00%)

As of 04:31 PM Eastern

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

LeMaitre Vascular NASDAQ:LMAT

$94.38 +1.76 (+1.90%)

Closing price 04:00 PM Eastern

Extended Trading

$94.34 -0.03 (-0.04%)

As of 06:09 PM Eastern

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time